UBS Group’s Senti Biosciences SNTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.31K | Sell |
4,412
-39,072
| -90% | -$82.4K | ﹤0.01% | 7572 |
|
|
2025
Q1 | $146K | Buy |
43,484
+24,515
| +129% | +$82.4K | ﹤0.01% | 5509 |
|
|
2024
Q4 | $66.6K | Buy |
18,969
+8,472
| +81% | +$29.7K | ﹤0.01% | 5902 |
|
|
2024
Q3 | $23.7K | Buy |
+10,497
| New | +$23.7K | ﹤0.01% | 6064 |
|
|
2024
Q2 | – | Sell |
-73
| Closed | -$276 | – | 8730 |
|
|
2024
Q1 | $276 | Buy |
+73
| New | +$276 | ﹤0.01% | 7489 |
|
|
2023
Q4 | – | Sell |
-20
| Closed | -$83 | – | 8511 |
|
|
2023
Q3 | $83 | Buy |
+20
| New | +$83 | ﹤0.01% | 7781 |
|
|
2023
Q2 | – | Sell |
-540
| Closed | -$6.37K | – | 8355 |
|
|
2023
Q1 | $6.37K | Sell |
540
-42
| -7% | -$495 | ﹤0.01% | 6829 |
|
|
2022
Q4 | $8.2K | Sell |
582
-383
| -40% | -$5.4K | ﹤0.01% | 7611 |
|
|
2022
Q3 | $21K | Buy |
965
+964
| +96,400% | +$21K | ﹤0.01% | 6247 |
|
|
2022
Q2 | $0 | Sell |
1
-214
| -100% | – | ﹤0.01% | 9698 |
|
|
2022
Q1 | $21K | Buy |
+215
| New | +$21K | ﹤0.01% | 6362 |
|